MX2022002314A - Prediccion del riesgo de eventos cardiovasculares y sus usos. - Google Patents

Prediccion del riesgo de eventos cardiovasculares y sus usos.

Info

Publication number
MX2022002314A
MX2022002314A MX2022002314A MX2022002314A MX2022002314A MX 2022002314 A MX2022002314 A MX 2022002314A MX 2022002314 A MX2022002314 A MX 2022002314A MX 2022002314 A MX2022002314 A MX 2022002314A MX 2022002314 A MX2022002314 A MX 2022002314A
Authority
MX
Mexico
Prior art keywords
cardiovascular risk
risk event
event prediction
prediction
cardiovascular
Prior art date
Application number
MX2022002314A
Other languages
English (en)
Spanish (es)
Inventor
Michael Hinterberg
Gargi Datta
Original Assignee
Somalogic Operating Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Operating Co Inc filed Critical Somalogic Operating Co Inc
Publication of MX2022002314A publication Critical patent/MX2022002314A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/324Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
MX2022002314A 2019-09-03 2020-09-02 Prediccion del riesgo de eventos cardiovasculares y sus usos. MX2022002314A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962895383P 2019-09-03 2019-09-03
PCT/US2020/048981 WO2021046074A1 (en) 2019-09-03 2020-09-02 Cardiovascular risk event prediction and uses thereof

Publications (1)

Publication Number Publication Date
MX2022002314A true MX2022002314A (es) 2022-06-02

Family

ID=72521733

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022002314A MX2022002314A (es) 2019-09-03 2020-09-02 Prediccion del riesgo de eventos cardiovasculares y sus usos.

Country Status (11)

Country Link
US (1) US20220349904A1 (https=)
EP (1) EP4025916A1 (https=)
JP (2) JP7712913B2 (https=)
KR (1) KR20220057534A (https=)
CN (1) CN114641692B (https=)
AU (1) AU2020343243A1 (https=)
BR (1) BR112022003666A2 (https=)
CA (1) CA3151482A1 (https=)
IL (1) IL290951A (https=)
MX (1) MX2022002314A (https=)
WO (1) WO2021046074A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025173327A1 (ja) * 2024-02-14 2025-08-21 Necソリューションイノベータ株式会社 罹患死亡可能性予測モデル、罹患死亡可能性予測方法、罹患死亡可能性予測装置、プログラム、及び記録媒体

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001577A (en) 1998-06-08 1999-12-14 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US5705337A (en) 1990-06-11 1998-01-06 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US5763177A (en) 1990-06-11 1998-06-09 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
EP0786469B1 (en) 1990-06-11 2006-03-01 Gilead Sciences, Inc. Methods of use of nucleic acid ligands
US5580737A (en) 1990-06-11 1996-12-03 Nexstar Pharmaceuticals, Inc. High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
US6458539B1 (en) 1993-09-17 2002-10-01 Somalogic, Inc. Photoselection of nucleic acid ligands
US6242246B1 (en) 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
WO2008056034A1 (en) * 2006-11-10 2008-05-15 Hytest Ltd. Stable standards for bnp immunoassays
EP2302395B1 (en) * 2006-06-07 2015-04-15 Health Diagnostic Laboratory, Inc. Markers associated with arteriovascular events and methods of use thereof
US7855054B2 (en) 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
DK2172566T4 (da) 2007-07-17 2022-06-13 Somalogic Inc Fremgangsmåde til generering af aptamerer med forbedrede off-rates
WO2012006632A2 (en) 2010-07-09 2012-01-12 Somalogic, Inc. Lung cancer biomarkers and uses thereof
KR20120101064A (ko) * 2009-11-13 2012-09-12 비쥐 메디신, 인코포레이티드 심근 경색의 위험 인자 및 예측
EP2593566B1 (en) * 2010-07-14 2018-01-24 The Regents of The University of California Biomarkers for diagnosis of transient ischemic attacks
CN103429753A (zh) 2010-09-27 2013-12-04 私募蛋白质体公司 间皮瘤生物标记及其用途
MX373248B (es) * 2011-09-30 2020-05-11 Somalogic Operating Co Inc Prediccion de riesgo de evento cardiovascular y usos del mismo.
EP2835641A1 (en) * 2013-08-09 2015-02-11 Inotrem Methods and kits for predicting the risk of having a cardiovascular disease or event
ES2792227T3 (es) * 2014-09-26 2020-11-10 Somalogic Inc Predicción de evento de riesgo cardiovascular y usos de la misma
CN108291330A (zh) * 2015-07-10 2018-07-17 西弗吉尼亚大学 卒中和卒中严重性的标志物

Also Published As

Publication number Publication date
JP2025118715A (ja) 2025-08-13
JP2022546515A (ja) 2022-11-04
CN114641692A (zh) 2022-06-17
US20220349904A1 (en) 2022-11-03
CN114641692B (zh) 2025-09-16
AU2020343243A1 (en) 2022-03-10
CA3151482A1 (en) 2021-03-11
JP7712913B2 (ja) 2025-07-24
IL290951A (en) 2022-04-01
WO2021046074A1 (en) 2021-03-11
EP4025916A1 (en) 2022-07-13
KR20220057534A (ko) 2022-05-09
BR112022003666A2 (pt) 2022-05-24

Similar Documents

Publication Publication Date Title
ZA202102612B (en) Reporting beam failure
MX2022010190A (es) Metodo de recepcion de informacion, metodo de envio de informacion y dispositivos.
BR112021019133A2 (pt) Método para comunicar informações de medição de posicionamento, terminal e dispositivo de rede.
BR112017014163A2 (pt) método para transmitir sinal de referência em célula que utiliza banda de frequência não licenciada e dispositivo
BR112022008264A2 (pt) Janela de transmissão e medição comum para transmissão e processamento de sinal de referência de posicionamento de downlink e uplink
CO2022002915A2 (es) Señalización dci con al menos un indicador de formato de ranura, sfi, campo e indicador de recurso de frecuencia
EP4376320A3 (en) Transmission configuration method, transmission configuration determination method, base station and terminal
BR112018069839A8 (pt) Estação-base, equipamento de usuário e método associado
BR112018003372A2 (pt) método para fornecer recomendações de barbeamento em estágios, programa de computador executável em uma unidade de processamento, sistema de cuidados pessoais, e aparelho de barbeamento
EA201791578A1 (ru) Панель биомаркеров для обнаружения рака
BR112021019878A2 (pt) Método e aparelho para determinar informações de feixe e dispositivo de comunicação.
BR112018068843A2 (pt) método de comunicação entre dispositivos, e dispositivo entre dispositivos
BR112016023534A2 (pt) método e aparelho para um mecanismo aperfeiçoado para selecionar um ponto de acesso
BR112019000742A2 (pt) método e kit para analisar uma amostra
BR112022005742A2 (pt) Método de configuração de recursos e aparelho, dispositivo e mídia de armazenamento.
SA520420124B1 (ar) مراقبة أداء خدمة تكنولوجيا معلومات شاملة
AR110117A1 (es) Búsqueda de conjuntos de señales de referencia de movilidad vecinas en movilidad nr basada en haces
BR112018003775A2 (pt) método e aparelho de gerenciamento de recursos
UY5036S (es) Cartucho de reactivo
PH12020551481A1 (en) Operation support system and operation support method for desulfurization apparatus
BR112016024480A2 (pt) seleção de célula mais rápida
WO2017197252A8 (en) Autism subsets
EP4348288A4 (en) User-aided signal line-of-sight (los) machine learning classifier
MX2022002314A (es) Prediccion del riesgo de eventos cardiovasculares y sus usos.
MX2019003648A (es) Metodo para evaluar la conformidad de un sistema de rastreo con un grupo de requerimentos y dispositivos asociados.